Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HERVAX 250 MG POLVO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/HERVAX 250 MG POLVO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

HERVAX 250 MG POLVO PARA SOLUCION PARA PERFUSION EFG

Medochemie Iberia S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 3, 2021
Approval ID: 01bb26f4bc3d852c
Company: Medochemie Iberia S.A.
Type: Standard

Approval Details

Approval Id: 01bb26f4bc3d852c
Drug Cima Aemps Name: HERVAX 250 MG POLVO PARA SOLUCION PARA PERFUSION EFG
Register Number: 85741
Holder Company Name: Medochemie Iberia S.A.
Marketing Company Name: Medochemie Iberia S.A. Sucursal En Espana
Authorization Date: 2021-02-03
Dosage Form: POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 250 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Medochemie Iberia S.A.

Active Ingredients

ACICLOVIR SODICO

274,402 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 3, 2021

Approval ID

01bb26f4bc3d852c

Type

Standard

Back to CIMA-AEMPS Approvals